Karla C Hurt - Eli Lilly and Company

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 24 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Effects of Tirzepatide on Circulatory Overload and End-Organ Damage in Heart Failure with Preserved Ejection Fraction and Obesity: a Secondary Analysis of the SUMMIT Trial

Barry A. Borlaug,Michael R. Zile,Christopher M. Kramer, Seth J. Baum,Karla Hurt,Sheldon E. Litwin, Masahiro Murakami, Yang Ou,Navneet Upadhyay,Milton Packer

NATURE MEDICINE (2024)

引用0浏览0WOSNATURE引用

Effects of Tirzepatide on the Clinical Trajectory of Patients with Heart Failure, Preserved Ejection Fraction, and Obesity

Michael R Zile,Barry A Borlaug,Christopher M Kramer, Seth J Baum,Sheldon E Litwin,Venu Menon, Yang Ou,Govinda J Weerakkody,Karla C Hurt,Chisom Kanu, Masahiro Murakami,Milton Packer, SUMMIT Trial Study Group

Circulationno. 10 (2024): 656-668

引用1浏览0WOS引用

Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy

Christopher M. Kramer,Barry A. Borlaug,Michael R. Zile,Dustin Ruff,Joseph M. DiMaria,Venu Menon, Yang Ou, Angela M. Zarante,Karla C. Hurt, Masahiro Murakami,Milton Packer

Journal of the American College of Cardiology (2024)

引用0浏览0WOS引用

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

Milton Packer,Michael R. Zile,Christopher M. Kramer, Seth J. Baum,Sheldon E. Litwin,Venu Menon,Junbo Ge,Govinda J. Weerakkody, Yang Ou, Mathijs C. Bunck,Karla C. Hurt, Masahiro Murakami,Barry A. Borlaug

The New England journal of medicineno. 5 (2024): 427-437

引用2浏览0WOS引用

Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure

Christopher M. Kramer,Barry A. Borlaug,Michael R. Zile,Dustin Ruff,Joseph M. DiMaria,Venu Menon, Yang Ou, Angela M. Zarante,Karla C. Hurt, Masahiro Murakami,Milton Packer

Journal of the American College of Cardiology (2024)

引用0浏览0引用

Table S1 from MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant As First-Line and Second-Line Therapy for HR+, HER2−-Advanced Breast Cancer

Patrick Neven,Stephen R.D. Johnston,Masakazu Toi, Joohyuk Sohn, Kenichi Inoue,Xavier Pivot,Olga Burdaeva,Meena Okera,Norikazu Masuda,Peter A. Kaufman,Han Koh,Eva-Maria Grischke,PierFranco Conte,Yi Lu,Nadine Haddad,Karla C. Hurt,Antonio Llombart-Cussac,George W. Sledge

openalex（2023）

引用0浏览0引用

Obesity and Metabolic Syndrome among Heart Failure with Preserved Ejection Fraction Patients

Lee Kallenbach,Jay P. Bae,David Nelson, Mac Bonafede,Kevin Lavelle,Karla Hurt, Masahiro Murakami

Circulation（2022）

引用0浏览0引用

Emonarcher: A Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Patients with HR+, HER2+, Node-Positive, High-Risk Early Breast Cancer

Sara M. Tolaney,Lesley Fallowfield,Peter A. Kaufman,Eva M. Ciruelos,Mary Corona Gainford,Yi Lu,Karla Hurt, Heather Ann Wasserstrom,Yanyun Chen,Shom Goel

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用1浏览0引用

Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in Premenopausal Women: Subgroup Analysis from the MONARCH 2 Trial

Neven Patrick,Rugo Hope S.,Tolaney Sara M.,Iwata Hiroji,Toi Masakazu,Goetz Matthew P.,Kaufman Peter A.,Lu Yi,Haddad Nadine,Hurt Karla C.,Sledge George W.

Breast Cancer Research（2021）

引用24浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn